On October 15, 2021, IDSA released revised remarks and a new evidence profile for the use of baricitinib for critically ill patients requiring invasive mechanical ventilation; this update has been endorsed by SIDP.

In legal rulings issued on Sept. 1 and Sept. 20, a federal judge in Texas dismissed all claims a group of Lyme disease patients had brought against the Infectious Diseases Society of America.  

Infections caused by bacteria resistant to multiple antibiotics led to $1.9 billion in health care costs, more than 400,000 days in the hospital and more than 10,000 deaths among older adults across the U.S. in 2017, according to a new study published today in Clinical Infectious Diseases.

IDSA, PIDS and SHEA recommend, in collaboration with the U.S. Centers for Disease Control and Prevention, that clinicians caring for these evacuees consider the varied presentations of medical conditions, including infectious diseases.

Dr. Collins has provided a steady, scientific voice throughout the COVID-19 pandemic. Under his leadership, NIH was instrumental in researching, developing and communicating about lifesaving COVID-19 vaccines and treatments. 

IDSA and the Centers for Disease Control and Prevention have announced they will continue their collaborative effort to support frontline health care professionals caring for patients with COVID-19.